Cagrilintide 5MG
Find your strength. Choose your bundle.
84 in stock (can be backordered)
Earn up to $3.86 back on this itemLazarus Pass · 1–5% store credit + free shipping protection · A$19.95/moA closer
look.
Cagrilintide (also written Cagri, and studied as AM833) is a synthetic long-acting analogue of the peptide hormone amylin, investigated in laboratory research for its interaction with amylin and calcitonin receptor pathways.
Lazarus Labs supplies Cagrilintide in Australia as a high-purity lyophilised reference material at ≥ 99 % purity, with a certificate of analysis for every lot.
Research details & references
Last reviewed:
For research use only — not for human or veterinary use.
What is Cagrilintide?
Research context
Cagrilintide belongs to the amylin-analogue class of research peptides. Laboratories study it in receptor-binding and signalling work alongside incretin-class compounds such as retatrutide and semaglutide, where comparative receptor-selectivity and stability experiments are common. Its extended half-life relative to native amylin is one of the properties most often examined in published in-vitro characterisation work. It is supplied strictly as a reference material for that research.
Specifications
- Total concentration: 5 mg per vial
- Purity: ≥ 99 %, confirmed by HPLC and LC-MS
- Form: white lyophilised powder
- Solubility: readily soluble in water (H₂O)
- Testing: every batch independently tested by Janoshik (HPLC + LC-MS)
- Documentation: third-party certificate of analysis per lot
- Intended use: in-vitro and laboratory research only
Quality & documentation
Every lot of Cagrilintide is independently tested by Janoshik Analytical. The certificate of analysis for your exact batch reports HPLC purity and LC-MS identity, so results stay traceable and reproducible — the standard of documentation that comparative and quantitative research depends on.
Handling & storage
Store sealed and dry at 2–8 °C. After reconstitution, keep prepared solution refrigerated and follow your laboratory’s own handling, stability, and disposal procedures. Cagrilintide is supplied for research use only and is not for human or veterinary use.
Dispatch & supply in Australia
Cagrilintide ships from Western Australia with tracked delivery, so research groups receive material quickly and in appropriate packaging. Every order includes the matching certificate of analysis.
Read the citation-backed research overview →
Cited research
- Kruse T, Hansen JL, Dahl K, et al. Journal of Medicinal Chemistry. 2021. PMID: 34288673.
- Hay DL, Chen S, Lutz TA, et al. Pharmacological Reviews. 2015. PMID: 26071095.
- Bower RL, Hay DL British Journal of Pharmacology. 2016. PMID: 27061187.
Primary literature, verified against PubMed. Cited for scientific reference only — no human-use indication is implied.
The finer
details.
Check the product format, available strengths and intended use.
- Product
- Cagrilintide 5MG
- Intended use
- Laboratory research only
- Documentation
- See COA tab for strength and batch reports
Read the report.
Know the batch.
Compare the product, strength and batch on your vial with the original laboratory document.
Supplier batch report
- Batch
- CS-ca51021
- Tested
- 2025-10-31
- Reported purity
- 99.839%
Reports identify tested batches. The available reports do not establish which batch will be dispatched with your order.
WA dispatch.
Tracked delivery.
Orders are dispatched from Western Australia with tracking. Check the selected product's availability and any pre-order notice before ordering.
Pre-order items follow their stated dispatch estimate. Orders containing pre-order items ship together once everything is available.
Shipping details →
